Work

IRF5 is a novel regulator of CXCL13 expression in breast cancer that increases CXCR5+ B and T cell trafficking to the tumor (TUM7P.955)

Year: 2014

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.192.supp.203.37

Authors: Erica Pimenta, Saurav De, Di Feng, Kelly Hall, Sophia Ran, Betsy Barnes

Institutions: Rutgers Health, SIU Medicine

Language: English

Topic: Chemokine receptors and signaling

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1506266207

Cites:

Cited by: 1

Related to: 10